S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Is This The End of Capitalism? (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Become an Investor in Brooklyn Gin (Ad)pixel
Cassava Sciences Stock Undervalued with Its $124 Price Target?
Why Extreme Networks is a Recession-Proof Technology Play
Become an Investor in Brooklyn Gin (Ad)pixel
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Grab Shares Are Suddenly On Track To Double
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Is This The End of Capitalism? (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Become an Investor in Brooklyn Gin (Ad)pixel
Cassava Sciences Stock Undervalued with Its $124 Price Target?
Why Extreme Networks is a Recession-Proof Technology Play
Become an Investor in Brooklyn Gin (Ad)pixel
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Grab Shares Are Suddenly On Track To Double
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Is This The End of Capitalism? (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Become an Investor in Brooklyn Gin (Ad)pixel
Cassava Sciences Stock Undervalued with Its $124 Price Target?
Why Extreme Networks is a Recession-Proof Technology Play
Become an Investor in Brooklyn Gin (Ad)pixel
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Grab Shares Are Suddenly On Track To Double
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Is This The End of Capitalism? (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Become an Investor in Brooklyn Gin (Ad)pixel
Cassava Sciences Stock Undervalued with Its $124 Price Target?
Why Extreme Networks is a Recession-Proof Technology Play
Become an Investor in Brooklyn Gin (Ad)pixel
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Grab Shares Are Suddenly On Track To Double
NASDAQ:IART

Integra LifeSciences - IART Stock Forecast, Price & News

$56.68
-1.55 (-2.66%)
(As of 01/30/2023 12:00 AM ET)
Add
Compare
Today's Range
$56.64
$58.01
50-Day Range
$53.10
$58.70
52-Week Range
$40.67
$68.29
Volume
357,157 shs
Average Volume
431,066 shs
Market Capitalization
$4.73 billion
P/E Ratio
27.51
Dividend Yield
N/A
Price Target
$58.33

Integra LifeSciences MarketRank™ Forecast

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
2.9% Upside
$58.33 Price Target
Short Interest
Bearish
5.31% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.50
Upright™ Environmental Score
News Sentiment
1.02mentions of Integra LifeSciences in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$15,685 Sold Last Quarter
Proj. Earnings Growth
5.39%
From $3.34 to $3.52 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.83 out of 5 stars

Medical Sector

818th out of 1,049 stocks

Surgical & Medical Instruments Industry

82nd out of 105 stocks


IART stock logo

About Integra LifeSciences (NASDAQ:IART) Stock

Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment. It operates through the Codman Specialty Surgical and Tissue Technologies segments. The Codman Specialty Surgical segment refers to the company's neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care, such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment, and the precision tools and instruments business, which sells instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices. The Tissue Technologies segment includes offerings such as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.

Receive IART Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integra LifeSciences and its competitors with MarketBeat's FREE daily newsletter.

IART Stock News Headlines

The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
What 6 Analyst Ratings Have To Say About Integra Lifesciences
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Integra LifeSciences Shares Surge On Q3 Beat
Integra Lifesciences: Q3 Earnings Insights
Expert Ratings for Integra Lifesciences
Integra LifeSciences Publishes Its Inaugural ESG Report
See More Headlines
Receive IART Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integra LifeSciences and its competitors with MarketBeat's FREE daily newsletter.

IART Company Calendar

Last Earnings
11/01/2021
Today
1/30/2023
Next Earnings (Confirmed)
2/22/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:IART
CUSIP
45798520
Employees
3,800
Year Founded
1989

Price Target and Rating

Average Stock Price Forecast
$58.33
High Stock Price Forecast
$75.00
Low Stock Price Forecast
$48.00
Forecasted Upside/Downside
+2.9%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

Net Income
$169.07 million
Pretax Margin
12.87%

Debt

Sales & Book Value

Annual Sales
$1.54 billion
Cash Flow
$4.58 per share
Book Value
$19.89 per share

Miscellaneous

Free Float
80,010,000
Market Cap
$4.73 billion
Optionable
Optionable
Beta
1.14

Social Links


Key Executives

  • Jan D. de Witte
    President, Chief Executive Officer & Director
  • Carrie L. Anderson
    Chief Financial Officer & Executive Vice President
  • William Compton
    Chief Information Officer & Senior Vice President
  • Robert T. Davis
    Executive VP & President-Tissue Technologies
  • Michael McBreenMichael McBreen
    EVP & President-Codman Specialty Surgical













IART Stock - Frequently Asked Questions

Should I buy or sell Integra LifeSciences stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Integra LifeSciences in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" IART shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IART, but not buy additional shares or sell existing shares.
View IART analyst ratings
or view top-rated stocks.

What is Integra LifeSciences' stock price forecast for 2023?

5 analysts have issued 1-year price targets for Integra LifeSciences' stock. Their IART share price forecasts range from $48.00 to $75.00. On average, they anticipate the company's stock price to reach $58.33 in the next twelve months. This suggests a possible upside of 2.9% from the stock's current price.
View analysts price targets for IART
or view top-rated stocks among Wall Street analysts.

How have IART shares performed in 2023?

Integra LifeSciences' stock was trading at $56.07 at the beginning of the year. Since then, IART stock has increased by 1.1% and is now trading at $56.68.
View the best growth stocks for 2023 here
.

When is Integra LifeSciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023.
View our IART earnings forecast
.

How can I listen to Integra LifeSciences' earnings call?

Integra LifeSciences will be holding an earnings conference call on Wednesday, February 22nd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Integra LifeSciences' earnings last quarter?

Integra LifeSciences Holdings Co. (NASDAQ:IART) posted its earnings results on Monday, November, 1st. The life sciences company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.72 by $0.14. The life sciences company had revenue of $386.86 million for the quarter, compared to the consensus estimate of $384.47 million. Integra LifeSciences had a trailing twelve-month return on equity of 16.41% and a net margin of 11.05%. The business's revenue was up 4.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.80 EPS.

When did Integra LifeSciences' stock split?

Integra LifeSciences shares split on the morning of Tuesday, January 3rd 2017. The 2-1 split was announced on Thursday, December 22nd 2016. The newly issued shares were distributed to shareholders after the market closes on Wednesday, December 21st 2016. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What guidance has Integra LifeSciences issued on next quarter's earnings?

Integra LifeSciences issued an update on its fourth quarter earnings guidance on Wednesday, January, 25th. The company provided earnings per share (EPS) guidance of $0.92-0.96 for the period, compared to the consensus EPS estimate of $0.90.

What is Peter J. Arduini's approval rating as Integra LifeSciences' CEO?

173 employees have rated Integra LifeSciences Chief Executive Officer Peter J. Arduini on Glassdoor.com. Peter J. Arduini has an approval rating of 74% among the company's employees.

What other stocks do shareholders of Integra LifeSciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Integra LifeSciences investors own include Boeing (BA), NVIDIA (NVDA), AbbVie (ABBV), Adobe (ADBE), Advanced Micro Devices (AMD), Gilead Sciences (GILD), Intel (INTC), Marvell Technology (MRVL), Alexion Pharmaceuticals (ALXN) and Abbott Laboratories (ABT).

What is Integra LifeSciences' stock symbol?

Integra LifeSciences trades on the NASDAQ under the ticker symbol "IART."

Who are Integra LifeSciences' major shareholders?

Integra LifeSciences' stock is owned by many different institutional and retail investors. Top institutional shareholders include Tributary Capital Management LLC (0.34%), Fort Washington Investment Advisors Inc. OH (0.27%), National Bank of Canada FI (0.06%), Yousif Capital Management LLC (0.04%), Dupont Capital Management Corp (0.04%) and Comerica Bank (0.04%). Insiders that own company stock include Eric Schwartz, Glenn Coleman, Jeffrey Mosebrook, Lisa Evoli, Michael J Mcbreen, Peter J Arduini, Raymond G Murphy, Richard E Caruso, Stuart Essig and Tru St Partnership, LP.
View institutional ownership trends
.

How do I buy shares of Integra LifeSciences?

Shares of IART stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Integra LifeSciences' stock price today?

One share of IART stock can currently be purchased for approximately $56.68.

How much money does Integra LifeSciences make?

Integra LifeSciences (NASDAQ:IART) has a market capitalization of $4.73 billion and generates $1.54 billion in revenue each year. The life sciences company earns $169.07 million in net income (profit) each year or $2.06 on an earnings per share basis.

How many employees does Integra LifeSciences have?

The company employs 3,800 workers across the globe.

Does Integra LifeSciences have any subsidiaries?
The following companies are subsidiares of Integra LifeSciences: ACell Inc, ACell Inc., Arkis BioSciences, Arkis Biosciences Inc., Ascension Orthopedics Inc., Ascension Orthopedics Limited, BIMECO Inc., BioD LLC, BioDlogics LLC, BioRecovery LLC, CardioDyne Inc., Cathtec Incorporated, Caveangle Limited, Codman Neuro, Confluent Surgical, Confluent Surgical Inc., Derma First Aid Products Inc., Derma Sciences, Derma Sciences Canada Inc., Derma Sciences Europe Limited, Derma Sciences Inc., EndoSolutions Inc., Fiber Imaging Technologies Inc., GMS Gesellschaft für medizinische Sondentechnik mbH, ILS Financing (Ireland) Limited, ILS Financing Corporation, ILS Services Switzerland Ltd., ILS Surgical Investments LLC, INS Sweden AB, Integra Burlington MA Inc., Integra CI Inc., Integra Canada ULC, Integra Euro Holdings Inc., Integra France Holdings SAS, Integra German Holdings GmbH, Integra GmbH, Integra Japan K.K., Integra LS (Benelux) NV, Integra LS Mexico S. DE R. L. DE C.V., Integra LifeSciences (Canada) Holdings Inc., Integra LifeSciences (Ireland) Limited, Integra LifeSciences (Shanghai) Co. Ltd., Integra LifeSciences Austria GmbH, Integra LifeSciences Brazil Ltda., Integra LifeSciences Corporation, Integra LifeSciences Enterprises LLLP, Integra LifeSciences Financing (Cyprus) Limited, Integra LifeSciences Italy S.r.l., Integra LifeSciences Middle East FZ-LLC, Integra LifeSciences Production Corporation, Integra LifeSciences Sales LLC, Integra LifeSciences Services (France) SAS, Integra LifeSciences Shared Services (Ireland) Limited, Integra LifeSciences Singapore Pte. Ltd., Integra LifeSciences Spain S.L., Integra LifeSciences Switzerland Sárl, Integra Luxtec Inc., Integra ME GmbH, Integra MicroFrance SAS, Integra NeuroSciences (International) Inc., Integra NeuroSciences Holdings (UK) Limited, Integra NeuroSciences Holdings B.V., Integra NeuroSciences Implants (France) SAS, Integra NeuroSciences Limited, Integra Neurosciences, Integra Neurosciences Pty Ltd. (AUS), Integra Neurosciences Pty Ltd. (NZ), Integra Receivables LLC, Integra Sales Inc., Integra Selector LLC, Integra Switzerland Holdings Sarl, Integra York PA Inc., IsoTis NV, IsoTis T.E. Facility B.V., J. Jamner Surgical Instruments Inc., Jarit GmbH, Kinetikos Medical, Koby Ventures II L.P. dba Metasurg, LXU Healthcare Inc. - Medical Specialty Products, MedEfficiency Inc., Medtronic Xomed Instrumentation SAS, Miltex, Minnesota Scientific Inc., Nantong Derma Medical Products Co. Ltd., Newdeal Inc., Newdeal SAS, Omni-Tract, Precise Dental Holding Corp., Precise Dental Internacional S.A. de C.V., Precise Dental Products Ltd., Precision Dental International Inc., Rebound Therapeutics, Rebound Therapeutics Corporation, Spembly Cryosurgery Limited, Spembly Medical Limited, TEI Biosciences (UK) Limited, TEI Biosciences Inc., TEI Biosciences Inc., TEI Medical Inc., TGX Medical Systems, TGX Medical Systems LLC, Tarsus Medical Inc., Tarsus Medical Inc., Tekmed Instruments S.p.A, Theken Disc, Theken Spine, and Therics.
Read More
How can I contact Integra LifeSciences?

Integra LifeSciences' mailing address is 311 ENTERPRISE DRIVE, PLAINSBORO NJ, 08536. The official website for the company is www.integralife.com. The life sciences company can be reached via phone at (609) 275-0500, via email at ir@integralife.com, or via fax at 609-750-4277.

This page (NASDAQ:IART) was last updated on 1/31/2023 by MarketBeat.com Staff